Stock Events

Stock Events

Ligand Pharmaceuticals (LGDN.STU) Q2 2026 Earnings

7MayConfirmed

Q2 2026

1.39

1.44

1.5

1.55

Details

Expected EPS

1.5482048563800002

Actual EPS

1.3898521

Surprise EPS

-0.16

Surprise Percent

+10.23%

Description

Ligand Pharmaceuticals (LGDN.STU) has reported earnings of 1.3898521 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.